Proprio Raises $43m Series B Funding to Fuel Commercialisation
First light field-enabled surgical technology company secures additional institutional capital to drive adoption of its AI-driven platform
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Jul 23
First light field-enabled surgical technology company secures additional institutional capital to drive adoption of its AI-driven platform
27 Jul 23
QIAGEN is a Netherlands-based holding company providing Sample to Insight solutions that enable customers to gain valuable molecular…
26 Jul 23
The FDA approval also includes the company’s core technology platform, the AXINON System, which incorporates diagnostic testing algorithms…
26 Jul 23
The ELEstic device can speed up sample processing, enable more samples to be processed in the same space…
25 Jul 23
The agreement builds on successful negotiations between New Day and Epigenomics and follows the US-based diagnostics company’s recent…
25 Jul 23
The Optrell catheter is a high-density diagnostic catheter to map cases like redo AFib ablation, persistent atrial fibrillation,…
25 Jul 23
Novel SaMD technology generates a 3D model of uterus to facilitate treatment in patients with symptomatic uterine fibroids
24 Jul 23
The company offers at-home health tests for evaluating various aspects such as sleep, fertility, gut health, stress, and…
24 Jul 23
Invivoscribe is a global, vertically-integrated biotechnology company dedicated to Improving Lives with Precision Diagnostics
21 Jul 23
XR90 is an augmented reality (AR) based diverse imaging platform used to visualise patient anatomy and instrumentation pathway,…